Objectives: This study was conducted to investigate the role of common variation in innate immunity-related genes as susceptibility factors to breast cancer risk in Korean women. Methods: Total 1536 single-nucleotide polymorphisms (SNPs) in 203 genes were analyzed by Illumina GoldenGate assay in 209 cases and the same numbers of controls. Both SNP and gene-based tests were used to evaluate the association with breast cancer risk. The robustness of results was further evaluated with permutation method, false discovery rate and haplotype analyses. Results: Both SNP and gene-based analyses showed promising associations with breast cancer risk for 17 genes: OR10J3, FCER1A, NCF4, CNTNAP1, CTNNB1, KLKB1, ITGB2, ALOX12B, KLK2, IRAK3, KLK4, STAT6, NCF2, CCL1, C1QR1, MBP and NOS1. The most significant association with breast cancer risk was observed for the OR10J3 SNP (rs2494251, P-value 5 1.2 3 10 24 ) and FCER1A SNP (rs7548864, P-value 5 7.7 3 10 24 ). Gene-based permutation and false discovery rate P-values for OR10J3 SNP (rs2494251) with breast cancer risk were also significant (P 5 4 3 10 25 and 0.008, respectively). Haplotype analyses supported these findings that OR10J3 and FCER1A were most significantly associated with risk for breast cancer (P 5 2 3 10 24 and 0.004, respectively). Conclusion: This study suggests that common genetic variants in the OR10J3 and FCER1A be strongly associated with breast cancer risk among Korean women.
Introduction
Breast cancer was the most common sporadic cancer among Korean women (1) . Multiple pieces of evidence suggest that environmental, hormonal and genetic factors have been implicated in the etiology and progression of breast cancer (2, 3) .
The genetic susceptibility to breast cancer implies that polymorphisms on cancer-related pathways contribute to the development and progression of breast cancer (4) . Epidemiologic studies reported that genetic variation that involved in the pathways of apoptosis/antiapoptosis, cytokines, DNA repair, cell adhesion and cell cycle/ proliferation, immune and inflammatory responses was associated with the risk of breast cancer (5) (6) (7) (8) .
A probable relationship between innate immune and inflammatory responses and breast cancer has been reported (9) (10) (11) . Previous report suggested that cytokines regulate angiogenesis of breast tumors and persistent oxidative stress increases the invasive potential of mammary epithelial cells (12, 13) . Furthermore, mice that were lacking in the inducible nitric oxide synthase, a proinflammatory enzyme, have a delayed onset of breast cancer (14) . The innate immune system plays a crucial role in the immune surveillance against malignancies and regulates survival and migration of tumor cells (9, 15) .
Although the relationship between innate immunity gene and breast cancer development has been proposed, only a few studies evaluated the association between genetic variant in innate immunity genes and breast cancer risk, and the genes involved in the innate immunity have not been systematically examined (7, 16) .
Thus, in this paper, we evaluated the association between candidate genetic variants in innate immunity-related genes and breast cancer risk in Korean women.
Method

Study population
Cases were patients diagnosed with histologically confirmed breast cancer in the Seoul National University Hospital during 2002-2004. Controls were consisted of healthy individuals who visited teaching hospitals located in the same city during the same periods for annual health checkup. These eligible controls were frequency matched to cases by menopausal status and 5-year age group. All study subjects were questioned about past medical history (e.g. tuberculosis, gall bladder) and family history of cancer, diabetes, stroke, hypertension and myocardiac infarction. The information was collected by welltrained interviewers with a structured questionnaire.
All participants in the study provided informed consent, and the study was approved by the Committee on Human Research of Seoul National University Hospital (IRB No. H-0503-144-004). Of 269 cases and 436 controls whose DNA samples remained enough for genotyping, 428 subjects were met the sample satisfying criteria (concentration .7.5 lg/ll, total amount of DNA .750 ng) by National Cancer Institute Core Genotyping Facility (http://cgf.nci.nih.gov). Of 428 samples (209 cases, 209 controls, 10 quality control samples), 117 cases and 194 controls were successfully genotyped.
Genotyping
Genotyping was performed on DNA extracted from peripheral blood with Gentra Puregene Blood Kit (Gentra, Minneapolis, MN) by the Illumina GoldenGate Assay at National Cancer Institute Core Genotyping Facility (http://cgf.nci.nih.gov).
A GoldenGate TM assay (Illumina, http://www.illumina.com) was designed using single-nucleotide polymorphisms (SNPs) in the SNP500Cancer project (http://snp500cancer.nci.nih.gov) with previous resequence data and the gene relating carcinogenic mechanism (17) .
Tag SNPs were selected in the region 20 kb 5# of the start of transcription (exon 1) and 10 kb 3# of the end of the last exon (N) of each candidate gene. Tag SNPs were chosen from the designable set of SNPs that were genotyped as part of the International HapMap (http://www.hapmap.org/index.html) and in later iterations using TagZilla (http://tagzilla.nci.nih.gov) with the following parameters: (i) genotypes from the HapMap Caucasian (CEU) samples for SNPs with a minor allele frequency . 5% and (ii) SNPs with a design score of ,0.4 were considered (http://www.illumina.com/downloads/ GoldenGateDesign_TechNote.pdf).
We obtained high-quality genotype calls with a median of SNPs per gene (range: 1-35 SNPs per gene). About 55% of these SNPs were located in introns, 7% in exons, 22% in promoter regions and 15% in 3# of stop codon.
Of the 1465 assays chosen for this study, 273 SNPs were removed from the analysis because of low minor allele frequency (,3%) or assay problems or deviation from Hardy-Weinberg equilibrium (exact P-value , 0.001). Thus, 1,192 SNPs in 203 innate immunity genes were used in the association analysis.
Overall completion in innate immunity on genomic DNA samples is 99.5% and the genotype call rate was 74.4%.
Statistical analysis
Genotype distribution was performed to examine deviation from the Hardy-Weinberg equilibrium in the control group using 'genetics' and 'dgc.genetics' packages in the R program (http://www.r-project.org).
The association between case-control status and each individual SNP was tested using a likelihood ratio test (LRT) with one degree of freedom according to the previous method (18) . A linear trend test was assumed a dose response with increasing number of variant alleles (genotype coding as 0, 1 and 2).
Unconditional logistic regression was employed to calculate odds ratios and their 95% confidence intervals for individual SNPs after adjustment of age (years), alcohol drinking status (never versus current), family history in the first degree relatives (yes versus no) and age at first full-term pregnancy. The variable age of first full-term pregnancy is divided into two categories, 25 years old and .25 years old including nulliparous.
We performed two gene-based tests for association. First, a LRT for each gene comparing models with and without terms for heterozygous and homozygous variant genotypes for each SNP in a given gene (df 5 2 Â number of SNPs per gene). Secondly, a LRT P-value was calculated for each gene comparing models with and without terms for each SNP (additive model) in a given gene (df 5 number of SNPs per gene). If SNPs were strongly correlated each other within a gene (r 2 . 0.90), we included one SNP in the model to avoid collinear matters.
Permuted P-values were obtained by running 1,000-300,000 permutations depending on the result of significance level. Gene-level false discovery rate (FDR) P-values were calculated with the ranked permuted P-values according to Benjamin-Hochberg method (Benjamin-Hochberg BH FDR) (19) .
Lastly, haplotype association, adjusted for covariates mentioned above, was assessed using unconditional logistic regression with the program haplo.stats (http://mayoresearch.mayo.edu/mayo/research/ schaid_lab/software.cfm).
Results
The general characteristics of the study population were similar to that of previously reported (data not shown) (20) .
SNP-based (Table I) and gene-based (Table II) analyses showed promising associations with breast cancer risk for 17 genes: OR10J3, FCER1A, NCF4, CNTNAP1, CTNNB1, KLKB1, ITGB2, ALOX12B, KLK2, IRAK3, KLK4, STAT6, NCF2, CCL1, C1QR1, MBP and NOS1.
The most significant association was for the variant in 3# of STP A.G of OR10J3 (rs2494251, Olfactory receptor, family 10, subfamily J, member 3) (P-value for trend test 5 1.2 Â 10 À4 ) ( Table I ). The next significant SNP was in the intron of FCER1A (rs7548864, IgE Fc receptor alpha-subunit gene) (P-value for trend test 5 7.7 Â 10 À4 ).
The results for gene-based analyses were quite concordant with SNP-based analyses (Table II) . The most significant association with breast cancer risk was observed for the OR10J3 gene (global trend P 5 2.5 Â 10 À5 , permuted P 5 4.0 Â 10 À5 ). OR10J3 was only significant with both the trend and gene-based FDR test (Table II) .
Consistent with SNP based analyses, haplotype analyses of OR10J3 and FCER1A were also associated with breast cancer risk (Table III) .
Discussion
Of 17 genes identified as a promising association with breast cancer risk by exploratory investigation of 1,536 SNPs in 203 genes involved innate immunity, the most significant association was observed with OR10J3.
Several previous reports have evaluated the association of one or two innate immunity gene polymorphism and breast cancer risk (7, 16, 21, 22) . Our results were compared with those from previous studies (21). Bernig et al. evaluated the association between 26 SNPs of MBL2, which were included in our oligonucleotides pool assay plate, and breast cancer in 166 African-American breast cases and 180 controls. None of the four SNPs overlapped in both studies were significantly associated with breast cancer. Genetic polymorphisms of interleukin-1 beta and interleukin-1 receptor antagonist, which are strong inducers of inflammation, were associated with decreased breast (22) . In Caucasian women, the presence of the À174C interleukin-6 allele increases the risk of breast cancer (7) . Although the OR10J3 SNP (rs2494251) is closely adjacent to FCER1A SNP (rs7548864) that is located in locus 1q23, these two SNPs were not in linkage disequilibrium (D' 5 0.62, r 2 5 0.21). The a-chain in FCER1-mediated allergic reaction was reported by the absence of allergic reaction in a-chain-deficient in vivo (23) and the relationship between FCER1A genetic variability and allergic disease was demonstrated in human studies (24) (25) (26) (27) . The significant SNP (rs225176) in the FCER1A gene in our analysis was the same SNP related to allergic diseases indicator (IgE) recently published in genome-wide association study (28) .
Possible mechanism explaining the association between FCER1A gene and breast cancer is that immune-stimulating conditions such as infectious diseases and allergies may actually confer susceptibility to breast cancer.
There are a few limitations in this study (e.g. small sample size, single-stage study design, tag SNPs selected based on the data of Caucasian population). However, this study was the first attempt to apply the comprehensive candidate gene approach to Asian population in breast cancer.
In summary, our finding suggested that common variants in the OR10J3 and FCER1A might be associated with a breast cancer among Korean women. Further large studies are required to confirm these findings, as well as to examine the biological mechanisms for the associations. 
